Detalhe da pesquisa
1.
Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome.
World J Urol
; 42(1): 173, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507059
2.
EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion.
J Pathol
; 259(3): 276-290, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441149
3.
Sensory Receptor, Inflammatory, and Apoptotic Protein Expression in the Bladder Urothelium of Patients with Different Subtypes of Interstitial Cystitis/Bladder Pain Syndrome.
Int J Mol Sci
; 24(1)2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614264
4.
Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
Int J Mol Sci
; 24(15)2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569430
5.
The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection.
Int J Mol Sci
; 25(1)2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203334
6.
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Int J Mol Sci
; 23(19)2022 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233356
7.
Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.
J Urol
; 205(1): 226-235, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856961
8.
Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients.
Int J Urol
; 28(8): 823-830, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966299
9.
Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Am J Physiol Renal Physiol
; 318(6): F1391-F1399, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32281420
10.
Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
Neurourol Urodyn
; 38(2): 703-709, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576011
11.
Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment.
Neurourol Urodyn
; 38(7): 1985-1993, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310370
12.
Upregulation of neurotrophins and transforming growth factor-ß expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis.
Neurourol Urodyn
; 38(8): 2303-2310, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433072
13.
Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome.
J Urol
; 200(3): 590-596, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653163
14.
Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity.
Neurourol Urodyn
; 37(8): 2651-2657, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797345
15.
Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Neurourol Urodyn
; 37(4): 1467-1473, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331031
16.
Histopathological characteristics of ketamine-associated uropathy and their clinical association.
Neurourol Urodyn
; 37(5): 1764-1772, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29441609
17.
Patient characteristics for different therapeutic strategies in the management ketamine cystitis.
Neurourol Urodyn
; 36(3): 687-691, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26998599
18.
Long-term follow up and predictive factors for successful outcome of transurethral incision of the bladder neck in women with detrusor underactivity.
J Formos Med Assoc
; 115(9): 807-13, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26375777
19.
Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
Int J Urol
; 22(9): 816-25, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087832
20.
Elevated serum IgE may be associated with development of ketamine cystitis.
J Urol
; 192(4): 1249-56, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859443